Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
The closing price of Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT) was $27.27 for the day, up 2.83% from the previous closing price of $26.52. In other words, the price has increased by $2.83 from its previous closing price. On the day, 0.67 million shares were traded. ARCT stock price reached its highest trading level at $28.3099 during the session, while it also had its lowest trading level at $26.765.
Ratios:
Our analysis of ARCT’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 4.72 and its Current Ratio is at 4.72. In the meantime, Its Debt-to-Equity ratio is 0.11 whereas as Long-Term Debt/Eq ratio is at 0.09.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Canaccord Genuity on December 13, 2023, initiated with a Buy rating and assigned the stock a target price of $90.
On July 24, 2023, William Blair started tracking the stock assigning a Outperform rating and target price of $71.
H.C. Wainwright Upgraded its Neutral to Buy on May 11, 2023, whereas the target price for the stock was revised from $19 to $51.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 25 ’24 when Chivukula Pad sold 17,435 shares for $35.02 per share. The transaction valued at 610,574 led to the insider holds 473,448 shares of the business.
Chivukula Pad sold 8,565 shares of ARCT for $299,839 on Mar 19 ’24. The Chief Scientific Officer & COO now owns 490,883 shares after completing the transaction at $35.01 per share. On Nov 01 ’23, another insider, Chivukula Pad, who serves as the Chief Scientific Officer & COO of the company, sold 5,000 shares for $18.72 each. As a result, the insider received 93,602 and left with 499,448 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ARCT now has a Market Capitalization of 734326592 and an Enterprise Value of 472189664. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.56 while its Price-to-Book (P/B) ratio in mrq is 2.63. Its current Enterprise Value per Revenue stands at 2.831 whereas that against EBITDA is -6.275.
Stock Price History:
Over the past 52 weeks, ARCT has reached a high of $43.81, while it has fallen to a 52-week low of $17.52. The 50-Day Moving Average of the stock is -17.41%, while the 200-Day Moving Average is calculated to be -8.34%.
Shares Statistics:
ARCT traded an average of 505.03K shares per day over the past three months and 487370 shares per day over the past ten days. A total of 26.83M shares are outstanding, with a floating share count of 24.57M. Insiders hold about 8.75% of the company’s shares, while institutions hold 88.78% stake in the company. Shares short for ARCT as of 1713139200 were 4613132 with a Short Ratio of 9.13, compared to 1710460800 on 4205886. Therefore, it implies a Short% of Shares Outstanding of 4613132 and a Short% of Float of 26.96.
